Global Conjunctivitis Treatment Market Size to Reach USD

Portland, OR, Oct. 03, 2022 (GLOBE NEWSWIRE) — A new business intelligence report released by Allied Market Research, the global Conjunctivitis Treatment Market generated $4.2 billion in 2021, and is estimated to reach $6.1 billion by 2031, manifesting a CAGR of 3.8% from 2022 to 2031. The report provides a detailed analysis of changing market dynamics, value chain, top segments, and competitive landscape. This report offers extensive information to assist market players, investors, stakeholders, and startups in devising strategies to maintain sustainable growth and avail competitive advantage in the market.

Download Free Sample Report (220 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/18049

Report coverage & details:

Covid-19 Scenario:

• The COVID-19 pandemic negatively affected the conjunctivitis treatment market as there were restrictions on transportation of drugs from one place to another due to lockdown restrictions.
• Manufacturing companies of drugs and pharmaceuticals that are required for conjunctivitis treatment faced major challenges including shortage and supply restrictions of raw materials utilized for drug formulations.
• Distribution channels suffered irregularities in demand for products from affected people. In addition, many treatment procedures were postponed to shift the focus on treating increase in the number of patients suffering from the Covid-19 and other life-threatening disorders. Treatments were carried out only in case of emergencies.
• The launch of new drugs was postponed due to disruptions in research and development activities and…